These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10719223)
1. New dopamine receptor, D2(Longer), with unique TG splice site, in human brain. Seeman P; Nam D; Ulpian C; Liu IS; Tallerico T Brain Res Mol Brain Res; 2000 Mar; 76(1):132-41. PubMed ID: 10719223 [TBL] [Abstract][Full Text] [Related]
2. Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. Tallerico T; Novak G; Liu IS; Ulpian C; Seeman P Brain Res Mol Brain Res; 2001 Mar; 87(2):160-5. PubMed ID: 11245917 [TBL] [Abstract][Full Text] [Related]
3. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats. See RE; Lynch AM; Sorg BA Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709 [TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
5. Are dopamine D2 receptors out of control in psychosis? Seeman P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():146-52. PubMed ID: 23880595 [TBL] [Abstract][Full Text] [Related]
6. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577 [TBL] [Abstract][Full Text] [Related]
7. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Hietala J; Cannon TD Arch Gen Psychiatry; 2005 Apr; 62(4):371-8. PubMed ID: 15809404 [TBL] [Abstract][Full Text] [Related]
8. Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants. Cravchik A; Sibley DR; Gejman PV Pharmacogenetics; 1999 Feb; 9(1):17-23. PubMed ID: 10208638 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Wilson JM; Sanyal S; Van Tol HH Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline. Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894 [TBL] [Abstract][Full Text] [Related]